Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: kendall harmon who wrote (322)	10/15/1999 12:24:00 AM
From: Miljenko Zuanic	Respond to of 3557

<<Dr. Benezra said he had already identified a chemical that inactivates the protein produced by the I.D. genes and is working with Angiogenex, a biotechnology company in Seattle, to evaluate it. >> I like this part. Inactivation of the protein by chemical (small molecules???). This news is more related to angiogenesis in general, but it did show that angio is complex and multiple mechanisms which can be disrupted in several way/key point. Hope, REGN will find small molecule which can regulate angio-1 and/or -2 activity, and finally move this program step further. Miljenko